AREVA PHARMS
GenericsAREVA PHARMS is a generic drug manufacturer focused on Respiratory, Infectious Disease.
AREVA PHARMS's Key Drugs
AREVA PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
AREVA PHARMS's Recent FDA Approvals
New NDA/BLA approvals for AREVA PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
AREVA PHARMS's Therapeutic Areas
AREVA PHARMS's approved drugs and pipeline span 2 therapeutic areas, led by Respiratory and Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AREVA PHARMS's Top Competitors
AREVA PHARMS's closest competitors by therapeutic-area and drug-target overlap include Merck, GSK, and GE HEALTHCARE. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
AREVA PHARMS Pipeline Snapshot
Active clinical trials for AREVA PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Respiratory pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2008-11-26
- Latest
- 2024-12-10
- Applications
- 5